Binding of busulfan to plasma proteins and blood cells
- 1 October 1984
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 36 (10) , 694-696
- https://doi.org/10.1111/j.2042-7158.1984.tb04847.x
Abstract
The reversible and non-reversible binding of busulfan to plasma proteins and to blood cells has been evaluated in man. The reversible binding to plasma proteins was insignificant in both healthy subjects and in patients with chronic myelocytic leukaemia. The percentage of busulfan irreveribly bound to plasma ligands was 32·4. Busulfan was distributed evenly between blood cells and plasma. The fraction of busulfan irreversibly bound to the blood cells was 46·9%. The major portion of busulfan that is degraded in whole blood reacts with the blood cells and the main part of that binds to macromoelcular components in the cells.Keywords
This publication has 8 references indexed in Scilit:
- Gas chromatographic determination of busulfan in plasma with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Determination of Busulfan in Plasma by GC-MS with Selected-Ion MonitoringJournal of Pharmaceutical Sciences, 1983
- Busulfan kineticsClinical Pharmacology & Therapeutics, 1983
- Protein binding of anthraquinone glycosides, with special reference to adriamycinCancer Chemotherapy and Pharmacology, 1982
- Degradation of Melphalan in Aqueous Solutions—Influence of Human Albumin BindingJournal of Pharmaceutical Sciences, 1982
- Degradation of chlorambucil in aqueous solution—influence of human albumin bindingJournal of Pharmacy and Pharmacology, 1981
- Pentazocine binding to blood cells and plasma proteinsClinical Pharmacology & Therapeutics, 1974
- The Chemistry of Cytotoxic Alkylating AgentsAdvances in Cancer Research, 1953